Nucleotide Microbial Synthesis Service
Characteristics of the Microbial Synthesis Method
Microorganisms are tiny organisms that are widely found in nature and are too small and numerous to be seen directly by the naked eye. Microorganisms can be categorized into prokaryotic, eukaryotic, and non-cellular microorganisms according to their evolutionary level and traits. The number of microorganisms in nature is roughly estimated to be in the order of millions, making them a rich and diverse resource on the earth. Nowadays, microbial technology is an integral part of bioengineering. Microbial technology has been successfully applied in various industries such as medicine, food, and textile. With the further development of biotechnology, it has become easier to build non-natural biomanufacturing systems based on microorganisms. For example, microorganisms can be used to efficiently produce protein macromolecules, DNA/RNA strands, and nucleotides.
Fig.1 Different forms of microorganisms. (Wikipedia)
Key Technologies
- Advanced Metabolic Pathway Engineering
We utilize state-of-the-art synthetic biology and genetic engineering techniques to precisely manipulate microbial metabolic pathways. This involves introducing novel genes, optimizing enzyme expression, and diverting metabolic flux towards the desired nucleotide sugar synthesis pathways. Our sophisticated bioinformatics tools and predictive modeling enable rational design for enhanced productivity and specificity.
- High-Throughput Screening and Directed Evolution
Our robust high-throughput screening platforms allow for rapid identification of high-performing microbial strains. Coupled with directed evolution strategies, we iteratively enhance the efficiency and yield of our engineered microbes, ensuring continuous improvement in production capabilities and expanding the library of accessible nucleotide sugars.
- Bioreactor Optimization
We employ advanced bioreactor design and process control strategies to create optimal growth and production environments for our microbial factories. This includes precise control over pH, temperature, aeration, and nutrient feeding, maximizing volumetric productivity and overall yield of the target nucleotide sugars.
Biosynthesis Unleashed: Sustainable Nucleotides at Industrial Scale
Nucleotides are an indispensable class of substances for human beings, and the microbial synthesis method has the advantages of mild conditions, high specificity, high production efficiency, simple operation, and low toxicity. Therefore, at CD BioGlyco, we will utilize the action of microorganisms themselves to produce nucleotides.
Principle of nucleotide synthesis by microbial method: utilizing the fermentation action of microorganisms.
To produce nucleotides more efficiently, we will optimize the metabolic pathways and regulatory mechanisms of microorganisms, and also improve the permeability of cell membranes for nucleotides.
In addition to the production of nucleotides by direct microbial fermentation, we offer the following production pathways:
- Microbial fermentation followed by chemical synthesis (phosphorylation reaction)
- The first step is microbial fermentation and the second step utilizes enzymatic conversion
During the production of nucleotides by microorganisms, we continuously optimize the reaction process and provide multiple production paths for clients to choose from.
Fig.2 Three methods of microbial synthesis. (CD BioGlyco)
Workflow
- Host & Pathway Design
We select or engineer a microbial host based on the target nucleotide sugar. Using in silico metabolic modeling, we map key biosynthesis pathways and identify bottlenecks.
- Genome Engineering
We apply CRISPR/Cas and base editing tools to modify the host genome: knocking out competing enzymes, overexpressing rate-limiting enzymes, and fine-tuning regulatory elements (e.g., ribosomal binding sites) to enhance flux.
- Fermentation Optimization
Engineered microbes are cultured in scalable bioreactors, with parameters (pH, temperature, nutrient supply) optimized to maximize nucleotide sugar accumulation. Fed-batch strategies are used to extend production phases and minimize product degradation.
- Purification
Nucleotide sugars are isolated from microbial lysates using a combination of ion-exchange chromatography and ultrafiltration, achieving. This step removes cellular contaminants, unreacted precursors, and byproducts.
Publication Data
DOI.: 10.1186/s12934-024-02452-8
Journal: Microbial Cell Factories
IF: 4.9
Published: 2024
Results: This study develops an engineered E. coli strain for enhanced guanosine production using combinatorial metabolic engineering. Researchers overexpressed Bacillus subtilis purine biosynthesis genes (Bspur operon) and PRPP synthase (prs), deleted guanosine catabolism genes (deoD, ppnP, gsk), and attenuated adenosine synthesis (purA). They redirected carbon flux by modifying EMP/ED pathways (deleting pfkA, edd, eda) and optimized redox cofactors. Transporter engineering (deleting nupG, overexpressing nepI) and strengthening guanosine synthesis (guaAB overexpression) further increased yield. The final strain achieved 289.8 mg/L guanosine in fed-batch fermentation – a 7-fold improvement over baseline, demonstrating efficient microbial nucleoside production.
Applications
- In food processing, nucleotides are used in the development of food additives for infants and children.
- Nucleotides are used in the development of intermediates for targeted therapeutic drugs.
- Nucleotides are used in the research of drugs for the treatment of AIDS.
Advantages
- Microbial synthesis of nucleotides is done under mild conditions and low toxicity and hence this helps in the application of nucleotides in drug production.
- Synthesis of nucleotides helps to explore the structure and function of nucleotides in depth.
- We have Custom Production Research Solutions that help our clients to conduct research with high quality.
Frequently Asked Questions
Associated Services
Building on the foundation of our nucleotide microbial synthesis, which provides essential nucleotide precursors for glycosylation pathways, we seamlessly extend to advanced glyco-engineered cell construction services. These include targeted solutions such as the GPI anchor pathway-based, glycolipids (GSL) pathway-based, and N-linked glycan pathway-based glyco-engineered cell construction services, enabling precise manipulation of cellular glycosylation for diverse applications.
CD BioGlyco has a first-class laboratory with biosynthesis technology in line with international high-level technology. We have been researching in the direction of producing nucleotides for many years and our technology has become more mature. We provide custom production to each of our clients. If you are interested in our services, please feel free to contact us.
Reference
- Zhang, K.; et al. Efficient production of guanosine in Escherichia coli by combinatorial metabolic engineering. Microbial Cell Factories. 2024, 23(1): 182. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




